A new pill helps people with hard-to-treat pancreatic cancer live longer
A new medicine called daraxonrasib helped people with advanced pancreatic cancer live longer than standard chemotherapy. In a trial of 500 patients whose cancer had already come back, the drug beat chemotherapy on how long people lived and how long the cancer stayed in check.